Compare Moderna, Inc. (MRNA) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Ralph Lauren Corp — how do they compare? Moderna, Inc. trades at $59.68 (market cap $23.60B), while Ralph Lauren Corp trades at $375.67 (market cap $22.41B). The key difference: Moderna, Inc. and Ralph Lauren Corp are close in size by market cap, and Ralph Lauren Corp pays a 0.99% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | RL | |
|---|---|---|
Market Cap | $23.60B | $22.41B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $414.25 |
52-Week Low | $22.36 | $283.34 |
Enterprise Value | $19.70B | $23.35B |
Dividend Yield | — | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
